<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="TAB1" orientation="portrait" position="float">
 <label>Table 1</label>
 <caption>
  <title>Randomized control trials for individual interventions</title>
  <p>*Due to the vast number of ongoing trials, trials in this chart are limited to those with &gt;500 participants</p>
  <p>NCT ID: National Clinical Trial Identifier; ACE: angiotensin-converting enzyme; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; COVID-19: coronavirus disease 2019</p>
 </caption>
 <table frame="hsides" rules="groups">
  <colgroup span="1">
   <col span="1"/>
   <col span="1"/>
   <col span="1"/>
   <col span="1"/>
   <col span="1"/>
  </colgroup>
  <tbody>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Intervention</td>
    <td rowspan="1" colspan="1">NCT ID</td>
    <td rowspan="1" colspan="1">No. of participants</td>
    <td rowspan="1" colspan="1">Duration</td>
    <td rowspan="1" colspan="1">Phase</td>
    <td rowspan="1" colspan="1">Sponsor</td>
   </tr>
   <tr>
    <td colspan="6" rowspan="1">Remdesivir</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: remdesivir; drug: standard of care</td>
    <td rowspan="1" colspan="1">NCT04292899</td>
    <td rowspan="1" colspan="1">6000</td>
    <td rowspan="1" colspan="1">March 2020–May 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Gilead Sciences</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: remdesivir; drug: standard of care</td>
    <td rowspan="1" colspan="1">NCT04292730</td>
    <td rowspan="1" colspan="1">1600</td>
    <td rowspan="1" colspan="1">March 2020–May 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Gilead Sciences</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Lopinavir</td>
    <td rowspan="1" colspan="1"> </td>
    <td rowspan="1" colspan="1"> </td>
    <td rowspan="1" colspan="1"> </td>
    <td rowspan="1" colspan="1"> </td>
    <td rowspan="1" colspan="1"> </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: lopinavir/ritonavir</td>
    <td rowspan="1" colspan="1">NCT04321174</td>
    <td rowspan="1" colspan="1">1220</td>
    <td rowspan="1" colspan="1">April 2020–March 2022</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Darrell Tan</td>
   </tr>
   <tr style="background-color:#ccc">
    <td colspan="6" rowspan="1">Tocilizumab</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: tocilizumab</td>
    <td rowspan="1" colspan="1">NCT04377750</td>
    <td rowspan="1" colspan="1">500</td>
    <td rowspan="1" colspan="1">April 2020–May 2021</td>
    <td rowspan="1" colspan="1">Phase 4</td>
    <td rowspan="1" colspan="1">Hadassah Medical Organization</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: tocilizumab; drug: placebo</td>
    <td rowspan="1" colspan="1">NCT04335071</td>
    <td rowspan="1" colspan="1">100</td>
    <td rowspan="1" colspan="1">April 2020–October 2020</td>
    <td rowspan="1" colspan="1">Phase 2</td>
    <td rowspan="1" colspan="1">University Hospital Inselspital, Berne</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: tocilizumab</td>
    <td rowspan="1" colspan="1">NCT04403685</td>
    <td rowspan="1" colspan="1">150</td>
    <td rowspan="1" colspan="1">May 2020–August 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Beneficência Portuguesa de São Paulo</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: tocilizumab; drug: placebo</td>
    <td rowspan="1" colspan="1">NCT04320615</td>
    <td rowspan="1" colspan="1">330</td>
    <td rowspan="1" colspan="1">April 2020–September 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Hoffmann-La Roche</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: tocilizumab</td>
    <td rowspan="1" colspan="1">NCT04331808</td>
    <td rowspan="1" colspan="1">228</td>
    <td rowspan="1" colspan="1">March 2020–December 2021</td>
    <td rowspan="1" colspan="1">Phase 2</td>
    <td rowspan="1" colspan="1">Assistance Publique - Hôpitaux de Paris</td>
   </tr>
   <tr style="background-color:#ccc">
    <td colspan="6" rowspan="1">Baricitinib</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: baricitinib; drug: placebo</td>
    <td rowspan="1" colspan="1">NCT04421027</td>
    <td rowspan="1" colspan="1">400</td>
    <td rowspan="1" colspan="1">June 2020–September 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Eli Lilly and Company</td>
   </tr>
   <tr style="background-color:#ccc">
    <td colspan="6" rowspan="1">ACEI</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: ACE inhibitor, angiotensin receptor blocker</td>
    <td rowspan="1" colspan="1">NCT04353596</td>
    <td rowspan="1" colspan="1">208</td>
    <td rowspan="1" colspan="1">April 2020–May 2021</td>
    <td rowspan="1" colspan="1">Phase 4</td>
    <td rowspan="1" colspan="1">Medical University Innsbruck</td>
   </tr>
   <tr style="background-color:#ccc">
    <td colspan="6" rowspan="1">Plasma apheresis*</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Biological: convalescent plasma</td>
    <td rowspan="1" colspan="1">NCT04348656</td>
    <td rowspan="1" colspan="1">1200</td>
    <td rowspan="1" colspan="1">May 2020–December 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Hamilton Health Sciences Corporation</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Biological: convalescent plasma; biological: standard donor plasma</td>
    <td rowspan="1" colspan="1">NCT04344535</td>
    <td rowspan="1" colspan="1">500</td>
    <td rowspan="1" colspan="1">April 2020–August 2021</td>
    <td rowspan="1" colspan="1">Phase 1, phase 2</td>
    <td rowspan="1" colspan="1">Stony Brook University</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Biological: SARS-CoV-2 convalescent plasma; biological: plasma from a volunteer donor</td>
    <td rowspan="1" colspan="1">NCT04373460</td>
    <td rowspan="1" colspan="1">1344</td>
    <td rowspan="1" colspan="1">June 2020–January 2023</td>
    <td rowspan="1" colspan="1">Phase 2</td>
    <td rowspan="1" colspan="1">Johns Hopkins University</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Biological: pathogen reduced SARS-CoV-2 convalescent plasma; biological: placebo</td>
    <td rowspan="1" colspan="1">NCT04362176</td>
    <td rowspan="1" colspan="1">500</td>
    <td rowspan="1" colspan="1">April 2020–April 2021</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Vanderbilt University Medical Center</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: plasma from COVID-19 convalescent patient; drug: human immunoglobulin</td>
    <td rowspan="1" colspan="1">NCT04381858</td>
    <td rowspan="1" colspan="1">500</td>
    <td rowspan="1" colspan="1">May 2020–September 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Centenario Hospital Miguel Hidalgo</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
